Polivaccinum mite Niesvoista shhepionka bakteriina
Ask a doctor about a prescription for Polivaccinum mite Niesvoista shhepionka bakteriina
How to use Polivaccinum mite Niesvoista shhepionka bakteriina
Package Leaflet: Information for the User
Polyvaccinum mite,suspension for injection
Non-specific bacterial vaccine
Inactivated bacteria: Staphylococcus aureus50 million cells , Staphylococcus epidermidis50 million
cells , Streptococcus salivarius10 million cells , Streptococcus pneumoniae10 million cells ,
Streptococcus pyogenes10 million cells , Escherichia coli20 million cells , Klebsiella pneumoniae10
million cells , Haemophilus influenzae10 million cells , Corynebacterium pseudodiphtheriticum20
million cells , Moraxella catarrhalis10 million cells/ 1 ml
Read the package leaflet carefully before using the vaccine, as it contains important information for the patient.
- Keep this leaflet, you may need to read it again.
- If you have any further questions, ask your doctor, pharmacist, or nurse.
- This vaccine has been prescribed specifically for you. Do not pass it on to others. The vaccine may harm another person, even if their symptoms are the same.
- If you experience any side effects, including any not listed in this leaflet, tell your doctor, pharmacist, or nurse. See section 4.
Table of Contents of the Leaflet
- 1. What is Polyvaccinum mite vaccine and what is it used for
- 2. Important information before using Polyvaccinum mite vaccine
- 3. How to use Polyvaccinum mite vaccine
- 4. Possible side effects
- 5. How to store Polyvaccinum mite vaccine
- 6. Package contents and other information
1. What is Polyvaccinum mite vaccine and what is it used for
Polyvaccinum mite is a bacterial vaccine that stimulates the immune system by containing killed bacteria that most often cause various types of infections or are the cause of complications of inflammatory conditions of non-bacterial origin. The vaccine is used prophylactically in recurring respiratory infections in children from 2 to 14 years and adults.
2. Important information before using Polyvaccinum mite vaccine
When not to use Polyvaccinum mite vaccine:
- if you are allergic to the active substances or any of the other ingredients of this medicine (listed in section 6). Allergy symptoms may include: itchy rash, shortness of breath, swelling of the face and tongue,
- if you have:
- infectious disease,
- acute inflammatory condition,
- kidney or liver disease,
- circulatory failure,
- systemic disease (a disease that affects several types of tissues and organs or the whole body),
- if you are taking immunosuppressive drugs (drugs that suppress the body's immune response),
- if you are pregnant or breastfeeding,
- in children under 2 years of age.
Warnings and precautions
Vaccination should be preceded by a medical examination and a medical history of the patient's general health and previously performed and recorded vaccinations. This procedure allows for predicting the risk of side effects and changing the dosing schedule. Be particularly careful if, after the previous dose of Polyvaccinum mite vaccine, side effects described in section 4 occurred or any other worrying reactions. The vaccine may be used during an infection if vaccination treatment was started before the development of the infection. It is not recommended to use the Polyvaccinum mite vaccine to prevent pneumonia, as there are no clinical trial data confirming such an effect.
For safety reasons, after vaccination, you should remain under medical observation for 30 minutes.
Polyvaccinum mite vaccine and other medicines
In patients undergoing immunosuppressive therapy (inhibiting the activity of the immune system), the response to the vaccine may be reduced. In such a case, the doctor may decide to postpone the vaccinations until the end of therapy. The vaccine can be used during antibiotic therapy if the doctor considers the administration of an antibiotic necessary. Tell your doctor about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take.
Pregnancy and breastfeeding
Do not use.
Driving and using machines
No studies have been conducted on the effect of the vaccine on the ability to drive and use machines.
3. How to use Polyvaccinum mite vaccine
Polyvaccinum mite vaccine will be administered by a doctor or nurse as an intramuscular or subcutaneous injection. The vaccine must never be administered intravenously. The vaccine is administered according to the dosing schedule along with Polyvaccinum submite and Polyvaccinum forte. The product does not replace anti-inflammatory treatment.
Dosage
Dosing schedule
| Injections administered at 3-5 day intervals | Adults | Children from 2 to 14 years | ||
| Vaccine | Dose | Vaccine | Dose | |
| Injection 1, 2, and 3 | Polyvaccinum submite | 1.0 ml | Polyvaccinum submite | 0.5 ml |
| Injection 4 and 5 | Polyvaccinum mite | 0.5 ml | Polyvaccinum submite | 1.0 ml |
| Injection 6, 7, and 8 | Polyvaccinum mite | 1.0 ml | Polyvaccinum mite | 0.3 ml |
| Injection 9 and 10 | Polyvaccinum forte | 0.3 ml | Polyvaccinum mite | 0.5 ml |
| Injection 11 and 12 | Polyvaccinum forte | 0.5 ml | Polyvaccinum forte | 0.2 ml |
| Injection 13 and 14 | Polyvaccinum forte | 1.0 ml | Polyvaccinum forte | 0.5 ml |
Dose 14 can be repeated at 2-4 week intervals for a period of 2-3 months. The full vaccination cycle shown in the table should be repeated 2 times a year, in the spring and autumn, for at least 2 years. Changing the dosage in case of prolonged or severe side effects is described in section 4.
Using a higher dose of Polyvaccinum mite vaccine than recommended
In case of using a higher dose of the vaccine than recommended, consult a doctor. Detailed information can be found at the end of the leaflet in the section "Information intended exclusively for healthcare professionals".
Missing a dose of Polyvaccinum mite vaccine
In case of doubt, consult a doctor.
Stopping the use of Polyvaccinum mite vaccine
In case of any further doubts about the use of this vaccine, consult a doctor, pharmacist, or nurse.
4. Possible side effects
Like all vaccines, this vaccine can cause side effects, although not everybody gets them.
Frequency not known (frequency cannot be estimated from the available data):
- headache
- nausea
- redness, swelling, pain at the injection site
- transient, lasting 6-8 hours fever (up to 38°C)
- malaise, general weakness
- local inflammatory conditions (exacerbation).
These symptoms usually resolve within 24 hours.
Warning:
In case of prolonged side effects such as headache, nausea, and general weakness, the time between injections should be extended and the vaccine dose reduced (return to the vaccine concentration containing ten times fewer bacteria and/or reduction of the vaccine dose volume).
Reporting side effects
If you experience any side effects, including any not listed in this leaflet, tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: 22 49-21-301, fax: 22 49-21-309, e-mail: [email protected]. Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medicine.
5. How to store Polyvaccinum mite vaccine
Store in a refrigerator (2°C - 8°C).
Store the vaccine out of sight and reach of children.
Do not use the vaccine after the expiry date stated on the carton.
The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
6. Package contents and other information
What Polyvaccinum mite vaccine contains
The active substances of the vaccine are inactivated (killed) bacteria:
Staphylococcus aureus, Staphylococcus epidermidis
50 million cells/1 ml
Escherichia coli, Corynebacterium pseudodiphtheriticum
20 million cells/1 ml
Streptococcus salivarius, Streptococcus pneumoniae, Streptococcus pyogenes, Klebsiella pneumoniae, Haemophilus influenzae,
Moraxella catarrhalis
10 million cells/1 ml
Other ingredients are: phenol, sodium chloride, disodium phosphate dodecahydrate, sodium dihydrogen phosphate dihydrate, and water for injections.
What Polyvaccinum mite vaccine looks like and what the package contains
The vaccine is an opalescent, colorless suspension. During storage, a white sediment forms at the bottom of the ampoule, and above it, a clear supernatant (liquid).
The package contains 5 ampoules of 1 ml each.
Marketing authorization holder and manufacturer
Biomed S.A.
Al. Sosnowa 8
30-224 Kraków
Tel.: +48 12 37 69 200
Fax: +48 12 37 69 205
e-mail: [email protected]
Date of last revision of the leaflet:
------------------------------------------------------------------------------------------------------------------------
Information intended exclusively for healthcare professionals:
Administration of Polyvaccinum mite vaccine
Shake before use. After shaking, Polyvaccinum mite vaccine is an opalescent, colorless suspension.
Visually inspect the vaccine for any foreign particles and/or changes in appearance. If any changes are observed, do not use the vaccine.
Administer intramuscularly or subcutaneously.
The recommended injection site is the deltoid muscle.
Do not administer intravenously! Ensure that the needle is not inserted into a blood vessel.
In case of using a higher dose of the vaccine than recommended, extend the time between injections and reduce the vaccine dose (return to the vaccine concentration containing ten times fewer bacteria and/or reduction of the vaccine dose volume).
Note: due to the risk of anaphylactic shock associated with vaccine administration, the vaccination room should be equipped with a standard emergency kit.
- Country of registration
- Prescription requiredNo
- Manufacturer
- ImporterInstytut Biotechnologii Surowic i Szczepionek BIOMED S.A.
- This information is for reference only and does not constitute medical advice. Always consult a licensed doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to Polivaccinum mite Niesvoista shhepionka bakteriinaDosage form: Powder, 10 mcg Haemophilus influenzae type b polysaccharide conjugated with 18-30 mcg tetanus toxoid/0.5 ml; 1 dose (0.5 ml)Active substance: haemophilus influenzae B, purified antigen conjugatedManufacturer: Sanofi PasteurPrescription requiredDosage form: Suspension, 1 dose (0.5 ml)Active substance: pertussis, purified antigen, combinations with toxoidsPrescription requiredDosage form: Powder, 2-8x10^6 CFU/mlActive substance: tuberculosis, live attenuatedManufacturer: AJ Vaccines A/SPrescription required
Alternatives to Polivaccinum mite Niesvoista shhepionka bakteriina in other countries
The best alternatives with the same active ingredient and therapeutic effect.
Alternative to Polivaccinum mite Niesvoista shhepionka bakteriina in Ukraine
Online doctors for Polivaccinum mite Niesvoista shhepionka bakteriina
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for Polivaccinum mite Niesvoista shhepionka bakteriina – subject to medical assessment and local rules.
Get updates and exclusive offers
Be the first to know about new services, marketplace updates, and subscriber-only promos.
